CCMU
ADMS
Cheyne Capital Management (UK)’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-100,000
| Closed | -$3.39M | – | 39 |
|
|
2017
Q4 | $3.39M | Sell |
100,000
-128,837
| -56% | -$4.36M | 1.48% | 17 |
|
|
2017
Q3 | $4.84M | Buy |
228,837
+120,000
| +110% | +$2.54M | 1.75% | 15 |
|
|
2017
Q2 | $1.9M | Sell |
108,837
-5,928
| -5% | -$104K | 0.73% | 26 |
|
|
2017
Q1 | $2.01M | Sell |
114,765
-30,000
| -21% | -$524K | 0.76% | 18 |
|
|
2016
Q4 | $2.45M | Buy |
144,765
+30,000
| +26% | +$507K | 1.38% | 9 |
|
|
2016
Q3 | $1.88M | Hold |
114,765
| – | – | 1.13% | 14 |
|
|
2016
Q2 | $1.74M | Buy |
114,765
+60,000
| +110% | +$908K | 1.4% | 8 |
|
|
2016
Q1 | $792K | Buy |
54,765
+40,000
| +271% | +$578K | 0.26% | 24 |
|
|
2015
Q4 | $418K | Sell |
14,765
-15,235
| -51% | -$431K | 0.23% | 26 |
|
|
2015
Q3 | $502K | Buy |
+30,000
| New | +$502K | 0.24% | 32 |
|